As growing strain on pharmaceutical technology necessitates more efficient practice, Alfa Laval has launched the CultureOne™, the industry’s first premium separator system for single-use cell culture processing. According to Bioplan Associates, single-use bioprocessing technologies now dominate the pre-commercial manufacturing space. However, Alfa Laval states many companies have not been able to make the transition to ‘full-single-use’ when harvesting proteins due to the lack of a single-use disc-stack centrifuge. The CultureOne™ overcomes this challenge and is said to make it easier for biopharmaceutical manufacturers processing smaller capacities. Alfa Laval is also working to ensure that the launch of the CultureOne™ is
The post Alfa Laval makes ‘full-single-use’ cell harvesting possible amid industry challenges appeared first on Pharma Mirror Magazine.
